Insider Trading & Ownership of Matthew K. Fust

Location
Novato, CA
Summary
The estimated net worth of Matthew K. Fust is at least $2,207,738 dollars as of 18 May 2026. Matthew K. Fust is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $1.02M. Matthew K. Fust is the Director of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $705.9K. Matthew K. Fust is the Director of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $342.4K. Matthew K. Fust is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $137.5K.
Signature
/s/ Karah Parschauer, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Matthew K. Fust and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Matthew K. Fust has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,207,738.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Crinetics Pharmaceuticals, Inc. ($1,021,911).
  • Past-year value change for that position: -$716,000.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Matthew K. Fust

Insider Transactions Reported by Matthew K. Fust:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .